DAX24.263 +0,7%ESt505.404 +0,5%Top 10 Crypto14,25 +0,6%Dow42.538 ±0,0%Nas19.437 +0,2%Bitcoin92.307 -0,4%Euro1,1424 +0,4%Öl64,80 -1,2%Gold3.373 +0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 RENK RENK73 NVIDIA 918422 BioNTech (ADRs) A2PSR2 HENSOLDT HAG000 Lufthansa 823212 Siemens Energy ENER6Y Tesla A1CX3T BYD A0M4W9 Infineon 623100 Bayer BAY001 BASF BASF11 Deutsche Bank 514000 Gerresheimer A0LD6E Mercedes-Benz Group (ex Daimler) 710000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX beendet Handel höher - neues Rekordhoch geknackt -- Airbus, CrowdStrike, NVIDIA, Infineon, Broadcom, Redcare, DHL im Fokus
Top News
NVIDIA-Aktie unter Druck: Läuft Huawei dem US-Chipriesen in China den Rang ab? NVIDIA-Aktie unter Druck: Läuft Huawei dem US-Chipriesen in China den Rang ab?
"Halte es nicht mehr aus": Bruch mit Trump? Musk kritisiert US-Steuerpaket scharf "Halte es nicht mehr aus": Bruch mit Trump? Musk kritisiert US-Steuerpaket scharf
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Sanofi Aktie

Handeln
Sanofi Aktien-Sparplan
43,20 EUR +0,60 EUR +1,41 %
STU
49,72 USD +0,52 USD +1,06 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone
KGV20,07Div. Rendite3,34%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN662283

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS80105N1054

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolSNY

Sanofi Aktien News

DatumMeistgelesen
ZacksThe Zacks Analyst Blog Highlights Meta Platforms, Sanofi, CME and The Cato
ZacksTop Stock Reports for Meta, Sanofi & CME
GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - July 2024
GlobeNewswirePress Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
EN, Sanofi-AventisPress Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
ZacksThe Zacks Analyst Blog AstraZeneca, Ionis and Sanofi
PR NewswireFluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
PR NewswireFluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
MotleyFoolSanofi (SNY) Q2 2024 Earnings Call Transcript
EN, Sanofi-AventisPress Release: Online availability of Sanofi’s half-year financial report for 2024
GlobeNewswirePress Release: Online availability of Sanofi’s half-year financial report for 2024
ZacksSanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
BenzingaSanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
GlobeNewswirePress Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
EN, Sanofi-AventisPress Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
BenzingaAstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
GlobeNewswireSanofi: Information concerning the total number of voting rights and shares – June 2024
GlobeNewswirePress Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
EN, Sanofi-AventisPress Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
PR NewswireSanofi ships U.S. influenza vaccines for the 2024/25 season
ZacksThe Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
GlobeNewswirePress Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
EN, Sanofi-AventisPress Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
BenzingaSanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
EN, Sanofi-AventisMedia Update: Frexalimab new phase 2 data showed reduction of key biomarker of nerve cell damage in relapsing MS
GlobeNewswirePress Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
EN, Sanofi-AventisPress Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
BenzingaSanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
BenzingaSanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
EN, Sanofi-AventisMedia Update: Riliprubart one-year follow-up from phase 2 study underpin the potential as a first-in-class treatment in chronic inflammatory demyelinating polyneuropathy
GlobeNewswirePress Release: Availability of the Q2 2024 Aide-mémoire
EN, Sanofi-AventisPress Release: Availability of the Q2 2024 Aide-mémoire
GlobeNewswirePress Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
EN, Sanofi-AventisPress Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
GlobeNewswirePress Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
EN, Sanofi-AventisPress Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
GlobeNewswirePress Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa
EN, Sanofi-AventisPress Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa
GlobeNewswireSanofi: Information concerning the total number of voting rights and shares – May 2024
PR NewswireI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.